The recovery on the German stock market continued on the second trading day of the week. The MDax, the index of medium-sized stocks, even climbed to a record high.
The recovery on the German stock market continued on the second trading day of the week. The MDax, the index of medium-sized stocks, even climbed to a record high.
For the German leading index Dax it was in early trading by 0.33 percent to 15,905.30 points up. It thus remains in close contact with its high of 16,030 points, which it reached in mid-August.
The MDax rose to just under 36,130 points. Then profits crumbled a little. Most recently there was an increase of 0.46 percent to 36,114.29 points. The leading Eurozone index EuroStoxx 50 gained 0.40 percent.
Among the individual values in the Dax, the last battered car values were again among the favorites and kept the Dax in the plus. VW gained 1.3 percent, Daimler and BMW 0.7 percent each. The paper from the supplier Continental rose by 1.0 percent.
Lanxess gained 0.8 percent in the MDax. The chemical company wants to expand its business around material protection and preservatives with another billion-dollar takeover in the USA. The antimicrobial protection products business of the manufacturer IFF is to be bought for around 1.3 billion US dollars (1.1 billion euros).
CTS Eventim and Dermapharm submitted quarterly reports. The ticket marketer CTS, shaken by the corona crisis, started to recover in the second quarter, but is still far from the pre-crisis level. In addition, there was still no specific forecast for business development for the year as a whole. The share gained 1.2 percent in the MDax.
The Dermapharm paper briefly jumped to a record high in the SDax. After a price of 78.40 euros was reached, however, it dropped by 4.2 percent. Here some investors obviously cashed in at the record level. The pharmaceutical company’s business continued to be driven by an unchanged high demand for preparations to strengthen the immune system, such as vitamin D products. The group also benefited from the corona vaccine production for Biontech.
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
